Envestnet Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$860K	Buy	61,948 +8,332	+16%	+$133K	﹤0.01%	3554
2025 Q4	$871K	Sell	53,616 -8,256	-13%	-$135K	﹤0.01%	3353
2025 Q3	$926K	Buy	61,872 +21,778	+54%	+$265K	﹤0.01%	3369
2025 Q2	$467K	Buy	+40,094	New	+$364K	﹤0.01%	3741
2024 Q2	–	Sell	-12,120	Closed	-$38.9K	–	4164
2024 Q1	$38.9K	Sell	12,120 -6,156	-34%	-$23.8K	﹤0.01%	4117
2023 Q4	$89.6K	Sell	18,276 -899	-5%	-$4.1K	﹤0.01%	3953
2023 Q3	$105K	Sell	19,175 -4,007	-17%	-$26.5K	﹤0.01%	3870
2023 Q2	$156K	Sell	23,182 -1,870	-7%	-$13.9K	﹤0.01%	3769
2023 Q1	$221K	Buy	25,052 +2,651	+12%	+$23.4K	﹤0.01%	3608
2022 Q4	$171K	Sell	22,401 -2,320	-9%	-$18.1K	﹤0.01%	3709
2022 Q3	$176K	Sell	24,721 -1,578	-6%	-$14.9K	﹤0.01%	3623
2022 Q2	$213K	Buy	26,299 +7,778	+42%	+$68.4K	﹤0.01%	3554
2022 Q1	$257K	Sell	18,521 -27,685	-60%	-$435K	﹤0.01%	3535
2021 Q4	$1.3M	Buy	46,206 +985	+2%	+$30.2K	﹤0.01%	2451
2021 Q3	$1.54M	Buy	45,221 +164	+0.4%	+$5.93K	﹤0.01%	2267
2021 Q2	$1.84M	Buy	45,057 +1,707	+4%	+$66.4K	﹤0.01%	2115
2021 Q1	$1.75M	Buy	43,350 +12,972	+43%	+$702K	﹤0.01%	2029
2020 Q4	$1.8M	Buy	30,378 +10,145	+50%	+$523K	﹤0.01%	1821
2020 Q3	$984K	Buy	20,233 +11,656	+136%	+$490K	﹤0.01%	2023
2020 Q2	$415K	Buy	+8,577	New	+$313K	﹤0.01%	2515